GuideCTF

GuideCTF

ICO Ended
12,461 Views
We are creating a management company GuideCTF, which will manage the index fund CIV20. The CIV20 index is our development, it is unique. The index includes the 20 largest and most popular crypto currencys every day. The index is updated every Monday. To buy the 20 largest currencies, it's enough to buy one CIV20 token.

The managing company GuideCTF takes charge for the management of the fund. The holder of the GCTF tokens receives dividends that are paid from the profits of the managing company GuideCTF.
2.8
TOTAL SCORE
5
ICO PROFILE

(weight: 45%)

1
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
ICO Time: 27 Oct 2017 - 29 Dec 2017
Country: Russia
Token info
Ticker: GCTF
Platform: Waves
Available for sale: 39,999,999 GCTF (45%)
Financial
ICO Price: 0.0562 USD
Accepting: BTC, ETH, LTС, WAVES
Soft cap: 1500000 USD
Social media
Jun-Jul 2017
Development of benchmark (index) for the cryptocurrency market
Jul 2017
Real time index calculation
Aug-Sep 2017
Business strategy and development plan preparation
Oct 2017
pre-ICO marketing assets attraction
Oct -Dec 2017
Marketing campaign<br />
Nov-Dec 2017
ICO startup capital attraction
Jan 2018
Registration of the management company as a legal entity (Jan-Mar2018 – Registration in SEC and MAS)
Feb-Apr 2018
Development of the company website and shareholders accounts
Mar 2018
Issue and distribution of GTCF smart contracts<br />
May 2018
Listing of company contracts on stock exchanges Registration of the fund management company Issue of the investment fund smart contracts
May-Jun 2018
Smart contract testing
Jun-Jul 2018
Development of accounts (for fund shareholders and partners)
Aug-Oct 2018
Security audit of the management company and the fund
Sept-Oct 2018
Security audit of the system kernel
Nov 2018
Registration in SEC and MAS
Dec 2018
Fund token ICO
Jan 2019
Placement on stock exchanges
Screenshots taken on 13 Feb 2018
Oleg Naumovich
CEO
No participating data
Egor Marchenko
CTO
No participating data
Stanislav Gaitsky
CMO
No participating data

Advisors (0)

HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Active
Rivalz
Rivalz is redefining AI infrastructure by creating an AI Intel Layer to unlock new agentic economies. Built on a dual-chain DePIN architecture using Dymension and Arbitrum, Rivalz addresses one of the biggest bottlenecks in AI today: access to AI-ready, verifiable, and secure data. As we envision the web3 space to become agentic and overtake humans in the amount of transactions over time, what Rivalz is building is key for enabling this future. The core challenge that Rivalz is addressing is the need for AI-ready, verifiable and accessible data and later on intelligence. Rivalz offers a hybrid solution combining decentralized storage and high-speed agent-centric connectivity networks that cater specifically to AI's demands, ushering in the era of the agentic economy.
Upcoming
Cryptocurrency Market
The sole aim of this Defi project is to bring trust and transparency to the blockchain and cryptocurrency space. Cryptocurrency Market is a platform that ensures trust for both service provider and procurement buyer. Cryptocurrency market provides a fundamental analysis of the crypto market in addition to tracking price, volume and market capitalization. Cryptocurrency Market is a professional marketplace powered by a Defi token, the project aimed at bringing absolute transparency and decentralization to the blockchain and cryptocurrency space, a professional platform that bears trust through a smart contract that allows both services providers and buyers to execute contracts without trust issues.
Upcoming
Data Choice
Take control of your personal data. Your data is used virtually every second you are online, to target you with ads. Data Choice will allow you to take control of what you share, what you keep private, control of the ads you see, and reward you for your data being used.
Upcoming
Plentix
The advent of cryptocurrencies and the tokenized economy makes it possible to re-imagine the entire value chain of consumer, products, and producers from a referral perspective. We present Plentix, a tokenized platform that enables users to refer other users to a business entity and enables business entities to leverage existing APIs for industry specific referrals and allows for safe, secure, trustless value exchange to take place. Unlike other referral platforms, Plentix unleashes the potential of a new global ecosystem to monetize referrals for every stakeholder, from the producer to the consumer.
Upcoming
ICOHeadStart
ICO HeadStart™ is the safest ICO fundraising platform in the world. Our experienced team of compliance experts award only carefully selected ICOs with a seal of approval after screening before these ICOs get listed on the ICO HeadStart™ platform adhering to give our community access to the best possible ICO proposals and the highest security standards in the ecosystem. In return for ETH and BTC the community receives MOAT along with voting points. Through voting the community decides which of these ICOs get funded. Elected projects receive their funds through Escrow 2.0 after the smart contract conditions have been met. ICO HeadStart's profits will be shared for 100%: 80% will be used to exchange back MOAT from the community and 20% will be used to give funded ICOs a head start. Decentralized, transparant, simple, honest.
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.